|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD (O.G.-A., M.J.E., J.N., E.S.); and the Departments of Pharmacology (B.I.G.), Neurology (H.I.H.), and Pathology and Laboratory Medicine (V.M.-Y.L., J.Q.T.), University of Pennsylvania School of Medicine, Philadelphia, PA.
* To whom correspondence should be addressed. E-mail: sidranse{at}mail.nih.gov.
Abstract-- The synucleinopathies are neurodegenerative disorders defined by inclusions composed of aberrantly fibrillized
-synuclein, but factors contributing to this process remain largely unknown. The authors examined the glucocerebrosidase gene in 75 autopsy specimens with different synucleinopathies and identified mutations in 23% of cases of dementia with Lewy bodies, expanding on previous findings in subjects with Parkinson disease. Mutations in this lysosomal protein may interfere with the clearance or promote aggregation of
-synuclein.
This article has been cited by other articles:
![]() |
E. Sidransky, M.A. Nalls, J.O. Aasly, J. Aharon-Peretz, G. Annesi, E.R. Barbosa, A. Bar-Shira, D. Berg, J. Bras, A. Brice, et al. Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease N. Engl. J. Med., October 22, 2009; 361(17): 1651 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neumann, J. Bras, E. Deas, S. S. O'Sullivan, L. Parkkinen, R. H. Lachmann, A. Li, J. Holton, R. Guerreiro, R. Paudel, et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease Brain, July 1, 2009; 132(7): 1783 - 1794. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Sheei-Meei Wang, J R Burke, D C Steffens, C M Hulette, J C S Breitner, and B L Plassman Twin pairs discordant for neuropathologically confirmed Lewy body dementia J. Neurol. Neurosurg. Psychiatry, May 1, 2009; 80(5): 562 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Clark, L. A. Kartsaklis, R. Wolf Gilbert, B. Dorado, B. M. Ross, S. Kisselev, M. Verbitsky, H. Mejia-Santana, L. J. Cote, H. Andrews, et al. Association of Glucocerebrosidase Mutations With Dementia With Lewy Bodies Arch Neurol, May 1, 2009; 66(5): 578 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lesage and A. Brice Parkinson's disease: from monogenic forms to genetic susceptibility factors Hum. Mol. Genet., April 15, 2009; 18(R1): R48 - R59. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Segarane, A. Li, R. Paudel, S. Scholz, J. Neumann, A. Lees, T. Revesz, J. Hardy, C. J. Mathias, N. W. Wood, et al. GLUCOCEREBROSIDASE MUTATIONS IN 108 NEUROPATHOLOGICALLY CONFIRMED CASES OF MULTIPLE SYSTEM ATROPHY Neurology, March 31, 2009; 72(13): 1185 - 1186. [Full Text] [PDF] |
||||
![]() |
W. C. Nichols, N. Pankratz, D. K. Marek, M. W. Pauciulo, V. E. Elsaesser, C. A. Halter, A. Rudolph, J. Wojcieszek, R. F. Pfeiffer, T. Foroud, et al. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset Neurology, January 27, 2009; 72(4): 310 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Goker-Alpan, G. Lopez, J. Vithayathil, J. Davis, M. Hallett, and E. Sidransky The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations Arch Neurol, October 1, 2008; 65(10): 1353 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mizuno, N. Hattori, S.-i. Kubo, S. Sato, K. Nishioka, T. Hatano, H. Tomiyama, M. Funayama, Y. Machida, and H. Mochizuki Progress in the pathogenesis and genetics of Parkinson's disease Phil Trans R Soc B, June 27, 2008; 363(1500): 2215 - 2227. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. F. Mata, A. Samii, S. H. Schneer, J. W. Roberts, A. Griffith, B. C. Leis, G. D. Schellenberg, E. Sidransky, T. D. Bird, J. B. Leverenz, et al. Glucocerebrosidase Gene Mutations: A Risk Factor for Lewy Body Disorders Arch Neurol, March 1, 2008; 65(3): 379 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Clark, B. M. Ross, Y. Wang, H. Mejia-Santana, J. Harris, E. D. Louis, L. J. Cote, H. Andrews, S. Fahn, C. Waters, et al. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease Neurology, September 18, 2007; 69(12): 1270 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bogaerts, S. Engelborghs, S. Kumar-Singh, D. Goossens, B. Pickut, J. van der Zee, K. Sleegers, K. Peeters, J.-J. Martin, J. Del-Favero, et al. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder Brain, September 1, 2007; 130(9): 2277 - 2291. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-K. Tan, J. Tong, S. Fook-Chong, Y. Yih, M.-C. Wong, R. Pavanni, and Y. Zhao Glucocerebrosidase Mutations and Risk of Parkinson Disease in Chinese Patients Arch Neurol, July 1, 2007; 64(7): 1056 - 1058. [Full Text] [PDF] |
||||
![]() |
A. Di Fonzo, H. F. Chien, M. Socal, S. Giraudo, C. Tassorelli, G. Iliceto, G. Fabbrini, R. Marconi, E. Fincati, G. Abbruzzese, et al. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease Neurology, May 8, 2007; 68(19): 1557 - 1562. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |